Takhzyro 300 mg/2 mL (150 mg/mL) prefilled syringe Images
Generic Name: lanadelumab
This medication has been identified as Takhzyro 300 mg/2 mL (150 mg/mL) prefilled syringe and is used for Hereditary Angioedema. It belongs to the drug class hereditary angioedema agents and is not a controlled substance.
Images of medication
Takhzyro
- Generic Name
- lanadelumab
- Strength
- 300 mg/2 mL (150 mg/mL) prefilled syringe
- Availability
- Prescription only
- Drug Class
- Hereditary angioedema agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Takeda Pharmaceutical Company Limited
- National Drug Code (NDC)
- 47783-0646
See also:
More about Takhzyro (lanadelumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: hereditary angioedema agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.